The Antioxidant Effects of Genistein Are Associated with AMP-Activated Protein Kinase Activation and PTEN Induction in Prostate Cancer Cells

다국어 초록 (Multilingual Abstract)

Epidemiological evidence suggests a lower incidence of prostate cancer in Asian countries, where soy products are more frequently consumed than in Western countries, indicating that isoflavones from soy have chemopreventive activities in prostate cells. Here, we tested the effects of the soy isoflavone genistein on antioxidant enzymes in DU145 prostate cancer cells. Genistein significantly decreased reactive oxygen species levels and induced the expression of the antioxidant enzymes manganese (Mn) superoxide dismutase (SOD) and catalase, which were associated with AMP-activated protein kinase (AMPK) and phosphatase and tensin homolog deleted from chromosome 10 (PTEN) pathways. The induced expression of catalase, MnSOD, and PTEN were attenuated by pretreatment with a pharmacological inhibitor for AMPK, indicating the effects of genistein primarily depend on AMPK. Furthermore, PTEN is essential for genistein activity, as shown by PTEN transfection in PTEN-deficient PC3 cells. Thus, genistein induces antioxidant enzymes through AMPK activation and increased PTEN expression.

참고문헌 (Reference)

1 Patel L., "Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN" 11 : 764-768, 2001

2 Maehama T., "The tumor suppressor, PTEN=MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate" 273 : 13375-13378, 1998

3 Marsin AS, "The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase" 277 : 30778-30783, 2002

4 Klaunig JE, "The role of oxidative stress in carcinogenesis" 44 : 239-267, 2004

5 Choi SL, "The regulation of AMP-activated protein kinase by H2O2" 287 : 92-97, 2001

6 Virolle T., "The Egr-1 transcription factor directly activates PTEN during irradiation-induced signaling" 3 : 1124-1128, 2001

7 Adlercreutz CH, "Soybean phytoestrogen intake and cancer risk" 125 : 1960-, 1995

8 Kurahashi N., "Soy product and isoflavone consumption in relation to prostate cancer in Japanese men" 16 : 538-545, 2007

9 Han S., "Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgammaindependent signal pathways" 5 : 430-437, 2006

10 Stambolic V., "Regulation of PTEN transcription by p53" 8 : 317-325, 2001

11 Fruehauf JP, "Reactive oxygen species: a breath of life or death?" 13 : 789-794, 2007

12 Jung SN, "Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells" 29 : 713-721, 2008

13 Waite KA, "Phytoestrogen exposure elevates PTEN levels" 14 : 1457-1463, 2005

14 Dang ZC, "Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein" 278 : 962-867, 2003

15 Sulis ML, "PTEN: from pathology to biology" 13 : 478-483, 2003

16 Huo YY, "PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts" 44 : 1578-1591, 2008

17 Maehama T., "PTEN and myotubularin: novel phosphoinositide phosphatases" 70 : 247-279, 2001

18 Hebert JR, "Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study" 90 : 1637-1647, 1998

19 Stambolic V., "Negative regulation of PKB=Akt-dependent cell survival by the tumor suppressor PTEN" 95 : 29-39, 1998

20 Banerjee S., "Multi-targeted therapy of cancer by genistein" 269 : 226-242, 2008

21 Sarkar FH, "Mechanisms of cancer chemoprevention by soy isoflavone genistein" 21 : 265-280, 2002

22 Teresi RE, "Increased PTEN expression due to transcriptional activation of PPARgamma by lovastatin and rosiglitazone" 118 : 2390-2398, 2006

23 Steck PA, "Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers" 15 : 356-362, 1997

24 Suzuki K., "Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3" 99 : 846-852, 2002

25 Hwang JT, "Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase" 338 : 694-699, 2005

26 Wang J., "Genistein mechanisms and timing of prostate cancer chemoprevention in Lobund-Wistar rats" 10 : 143-150, 2009

27 Cui W., "Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice" 15 : 1943-1950, 2009

28 Cai Q., "Effect of dietary genistein on antioxidant enzyme activities in SENCA mice" 25 : 1-7, 1996

29 Jacobsen BK, "Does high soy milk intake reduce prostate cancer incidence? The Adventist health study (United States)" 9 : 553-557, 1998

30 Hwang JT, "Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways" 332 : 433-440, 2005

31 Hawley SA, "Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase" 271 : 27879-27887, 1996

32 Datta SR, "Cellular survival: a play in three Akts" 13 : 2905-2927, 1999

33 Malins DC, "Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors" 100 : 5401-5406, 2003

34 Bostwick DG, "Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer" 89 : 123-134, 2000

35 Lehmann JM, "An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor g (PPAR g)" 270 : 12953-12956, 1995